In a small study, sublingual immunotherapy (SLIT) was effective in desensitizing peanut-allergic toddlers, allowing 74 percent to consume 4,443 milligrams… Read more »
BY ALLERGIC LIVING When the U.S. Food and Drug Administration (FDA) approved a new oral immunotherapy (OIT) for peanut allergy… Read more »
With much of the Food and Drug Administration’s staff working on the coronavirus pandemic, the timeline for reviews of some… Read more »
By extending the peanut biologic oral immunotherapy known as AR101 by 28 weeks, a new study finds that a majority… Read more »
Researchers from the University of Michigan have developed a vaccine, given as a nasal spray, that stopped or greatly reduced… Read more »
All of the participants in the Phase II trial were able to tolerate nearly 2 peanut kernels at the end of two months.